Shandong Aobo Biotech Co.,Ltd is a production plant under the Aocter Group (Shandong Aocter Biotechnology Co., Ltd.). It has a number of scientific research and development and testing institutions and production workshops such as R & D centers, laboratories, inspection rooms, and strain rooms. The leading products are biological enzyme preparations, biological functional food, biological medicine raw materials, etc. It is mainly responsible for the research, development and production of high-tech biological fermentation, enzyme conversion, food nutrition fortification and other products under Aocter. The products are exported to 80 countries and regions. It is a national high-tech enterprise, a national intellectual property advantage enterprise, a gazelle enterprise in Shandong province, a specialized and special new small and medium-sized enterprise in Shandong Province, a technological innovation demonstration enterprise in Shandong Province, a provincial manufacturing single champion enterprise, and an enterprise technology center, a key laboratory and an engineering laboratory. Liaocheng is the first batch of "Liaocheng emerging pillar enterprises", Liaocheng "green factory". Through the ISO9001, ISO22000, HACCP, KOSHER and other related international certification. In 2020, we will cooperate with Shandong University team to pass the "Taishan Industry Leading Talents" project (strategic emerging category). In 2022, it will cooperate with Henan University to undertake the project of introducing urgently needed talents in key support areas of Shandong Province. Undertook the "Shandong Province old and new kinetic energy conversion major project library preferred project". In November 2023, it was included in the "pilot list of green, low-carbon and high-quality development pilot areas in Shandong Province".

Aobo Bio carries out production work around the global marketing network of Aocter Group, adhering to the tenet of "honest brand and global trust" of the group company, taking brand construction as the center, taking on and building the role of Aocter's high-precision and cutting-edge production base, and making positive contributions to the transformation and upgrading of Aocter Group and the transformation of new and old kinetic energy.

Accelerate innovation and development through cooperative research and development and benefit sharing with well-known research institutes and professors. The research and development platform forward, high-end technology positioning, in order to attract talent, retain talent, the use of talent to build a sustainable innovation development platform. At the same time with Shandong University, Zhejiang University of Technology, East China University of Science and Technology, Nankai University professor team cooperation project research and development. With these cooperation platforms and partners, the enterprise has realized the transformation and upgrading faster and higher, and the transformation of new and old kinetic energy, so that the enterprise presents the vitality of innovation and development. According to the current development momentum and project planning, it will transform to the pharmaceutical and health industry again from 2020. The planned national biomedical laboratory and its supporting GMP workshop are under construction and have been completed. Relying on the laboratory to build a post-doctoral research workstation, academician workstation related preliminary work has begun docking and preparation. By 2025, the production of raw materials and finished drugs will be gradually realized.